FIVE-YEAR OUTCOMES OF PEANUT ORAL IMMUNOTHERAPY FACILITATED INITIALLY BY OMALIZUMAB

Category Primary study
JournalAnnals of Allergy, Asthma and Immunology
Year 2024
This article has no abstract
Epistemonikos ID: 8c55d6e54e7ad9a8d29c2422f98232c047d2a341
First added on: Feb 19, 2025